Zobrazeno 1 - 10
of 153
pro vyhledávání: '"Tečić Vuger A"'
Publikováno v:
In Journal of Cancer Policy December 2024 42
Autor:
Toni Čeprnja, Snježana Tomić, Melita Perić Balja, Zlatko Marušić, Valerija Blažićević, Giulio Cesare Spagnoli, Antonio Juretić, Vesna Čapkun, Ana Tečić Vuger, Zenon Pogorelić, Ivana Mrklić
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 8, p 4513 (2024)
“Basal-like” (BL) morphology and the expression of cancer testis antigens (CTA) in breast cancer still have unclear prognostic significance. The aim of our research was to explore correlations of the morphological characteristics and tumor microe
Externí odkaz:
https://doaj.org/article/eb845dc22e494db391007e3a91fb8a69
Autor:
Mirjana Pavlović-Mavić, Petra Linarić, Ljubica Vazdar, Ana Tečić-Vuger, Petra Jakšić, Robert Šeparović
Publikováno v:
Libri Oncologici, Vol 51, Iss 2-3, Pp 109-118 (2023)
Body composition changes could indicate health conditions and potential health risks. Although several methods are currently available for quantitative assessment, each has limitations. Indirect methods are most frequently used because of their avail
Externí odkaz:
https://doaj.org/article/14d8fcc1aeed436a822539ffe66e0001
Publikováno v:
Acta Clinica Croatica, Vol 61., Iss 4, Pp 605-612 (2022)
Body composition has been studied relatively recently as part of oncology trials in different types of tumors. There are numerous studies that define the impact of chemotherapy side effects on the quality of life (QoL) of breast cancer patients, ho
Externí odkaz:
https://doaj.org/article/852e5b81a0f14f02aa28d439e6418e87
Autor:
Ljubica Vazdar, Ivo Darko Gabrić, Ivan Kruljac, Hrvoje Pintarić, Robert Šeparović, Lora Stanka Kirigin Biloš, Mirjana Pavlović, Ana Tečić Vuger, Mario Štefanović
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract Trastuzumab has improved the prognosis of HER2 positive breast cancer, but cardiotoxicity remains a concern. We aimed to identify risk factors for trastuzumab-induced cardiotoxicity, with an emphasis on the HER2 Ile655Val single nucleotide p
Externí odkaz:
https://doaj.org/article/b0792d63096946bf96cbd11450c1c581
Autor:
Ana Tečić-Vuger, Robert Šeparović, Ljubica Vazdar, Mirjana Pavlović, Petra Linarić, Sanda Šitić, Martina Šepetavc, Damir Vrbanec
Publikováno v:
Libri Oncologici, Vol 49, Iss 1, Pp 20-28 (2021)
Tumor stimulates specific innate and acquired immune mechanisms. Main carriers of body’s immune response to tumor are T lymphocytes and main mechanism is killing of tumor cells by cytotoxic T lymphocytes CD8 +. In some cases, immune system can also
Externí odkaz:
https://doaj.org/article/e57271a45e0f4dc0b44ca5c75d8df961
Autor:
Ana Tečić-Vuger, Robert Šeparović, Ljubica Vazdar, Mirjana Pavlović, Petra Lepetić, Sanda Šitić, Božena Šarčević, Damir Vrbanec
Publikováno v:
Libri Oncologici, Vol 48, Iss 1, Pp 20-26 (2020)
Androgen receptors (AR) are ligand-dependent nuclear transcription factors. These are steroid receptors, similar to estrogen receptors (ER). They are expressed in numerous cells in the body, with different constructive roles. AR signalling can be inv
Externí odkaz:
https://doaj.org/article/e675f03ec5d54e988e0048657e7140fc
Autor:
Ana Tečić Vuger, Robert Šeparović, Ljubica Vazdar, Mirjana Pavlović, Petra Lepetić, Sanda Šitić, Žarko Bajić, Božena Šarčević, Damir Vrbanec
Publikováno v:
Acta Clinica Croatica, Vol 59., Iss 1., Pp 97-107 (2020)
Triple-negative breast cancer (TNBC) occurs in around one-sixth of all breast cancer (BC) patients, with the most aggressive behavior and worst prognosis of all BC subtypes. It is a heterogeneous disease, with specific molecular characteristics and n
Externí odkaz:
https://doaj.org/article/46703ac2ee474f09acb499d757115aa0
Publikováno v:
Acta Clinica Croatica, Vol 59., Iss 4., Pp 761-764 (2020)
Oxaliplatin is part of the standard chemotherapy regimens for treating colorectal carcinoma. Pulmonary fibrosis is a serious but rare side effect of oxaliplatin treatment, which resulted in patient death in more than half of the reported cases. The
Externí odkaz:
https://doaj.org/article/929deec224cd4548a79d0c278616d434
Autor:
Ingrid Belac Lovasić, Martina Bašić Koretić, Paula Podolski, Natalija Dedić Plavetić, Tajana Silovski, Stjepko Pleština, Marijana Jazvić, Željko Soldić, Robert Šeparović, Ana Tečić Vuger, Lidija Beketić Orešković, Ilijan Tomaš, Josipa Flam, Branka Petrić Miše, Marija Ban, Vesna Telesmanić Dobrić, Anuška Budisavljević, Josipa Jović Zlatović, Marijo Nalbani, Željko Vojnović, Zlatko Marušić, Snježana Tomić, Manuela Avirović, Bojan Štambuk, Danko Velimir Vrdoljak, Maja Prutki, Boris Brkljačić, Tade Tadić, Davor Mijatović, Zdenko Stanec, Ivan Milas, Eduard Vrdoljak
Publikováno v:
Liječnički vjesnik, Vol 144, Iss 9-10, Pp 395-305 (2022)
Breast cancer is the most common cancer in women, which can be diagnosed early through screening, early detection and through education. When diagnosed early, it can be successfully treated. Treatment modalities include surgery, chemotherapy, radioth
Externí odkaz:
https://doaj.org/article/8b47de584e464a4896b007bbb6197d58